Contagion&reg Editorial Staff

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA approves tafenoquine tablets for the prevention of malaria in patients aged 18 and older.

Ellie J C Goldstein, MD, discusses how physicians need to rely on the data that is available when selecting an antibiotic.

We’ve compiled a list of product recalls issued by the US Food and Drug Administration (FDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Jason Gallagher discusses the responsibility of medical professionals to educate the community.

We’ve rounded up a list of important US Food and Drug Administration (FDA) recalls from this week.

Dale N Gerding, MD, discusses the most recent changes to the guidelines of C difficile and the concerns of long-term effects of fecal microbiome transplants.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, discusses the source of prediction scores and how antimicrobial stewards work in concert with other clinicians to develop prediction scores.

More information continues to come to light on the impact of protease inhibitors on patients with HIV and cardiovascular disease.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Samuel Shor, MD, FACP, explores the controversial concept of chronic Lyme disease and the role of antibiotic stewardship in treatment programs.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

In case you missed them, we’ve compiled the top 5 infectious disease articles from this past week.

Samuel, Shor, MD, FACP, discusses the potential link between chronic fatigue syndrome and Lyme disease.

The results indicate a significant link between sepsis and 15 cancers in elderly patients.

We’ve rounded up a list of important US Food and Drug Administration (FDA) recalls from this past week:

Stay up-to-date on the latest infectious disease news by reading the top 5 articles of the week.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, discusses how prediction scores are used to guide empiric therapy.

Barbara Wells Trautner, MD, PhD, discusses why physicians are using fluoroquinolones despite the FDA’s warning.

In case you missed them, we've compiled the top 5 articles from this past week.

Douglas Krakower, MD, discusses the challenges of predicting HIV acquisition in large populations using electronic health records.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, discusses how prediction scores are used in antibiotic stewardship programs.

Barbara Wells Trautner, MD, PhD, explains the risk of aortic dissection and aneurysm in patients taking oral fluoroquinolones.

Ellie J C Goldstein, MD, stresses the importance of improving transition of care with better communication.

Jason Gallagher, PharmD, discusses the clinical implications of the approval of plazomicin for health care providers and patients.

In case you missed them, we've compiled the top 5 articles from this past week.

The American Society for Microbiology’s (ASM) annual meeting, held June 7-11, 2018, in Atlanta, Georgia, featured results of numerous studies on and advancements being made in infectious diseases. Here are 5 key takeaways from the meeting.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.